PALMITIC MONOISOPROPANOLAMIDE, (R)-

CCCCCCCCCCCCCCCC(=O)NC[C@@H](C)O

InChIKey=VQNMGLLFMPXVFN-GOSISDBHSA-N

InChI=1S/C19H39NO2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-19(22)20-17-18(2)21/h18,21H,3-17H2,1-2H3,(H,20,22)/t18-/m1/s1

Targets

Primary Target	Pharmacology	Condition	Potency
Cannabinoid CB1 receptor 85 Target ID: CHEMBL218 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11498512	Binding Agent 1064
Cannabinoid CB2 receptor 71 Target ID: CHEMBL253 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11498512	Binding Agent 1064

PubMed

Title	Date	PubMed

Patents

Name

Type

Language

PALMITIC MONOISOPROPANOLAMIDE, (R)-

Common Name

English

HEXADECANAMIDE, N-((2R)-2-HYDROXYPROPYL)-

Systematic Name

English

Code System Code Type Description

EPA CompTox

DTXSID30170886

Created by admin on Sat Dec 16 05:41:37 GMT 2023 , Edited by admin on Sat Dec 16 05:41:37 GMT 2023

PRIMARY

PUBCHEM

18395309

Created by admin on Sat Dec 16 05:41:37 GMT 2023 , Edited by admin on Sat Dec 16 05:41:37 GMT 2023

PRIMARY

CAS

179951-56-5

Created by admin on Sat Dec 16 05:41:37 GMT 2023 , Edited by admin on Sat Dec 16 05:41:37 GMT 2023

PRIMARY

FDA UNII

3438DY3589

Created by admin on Sat Dec 16 05:41:37 GMT 2023 , Edited by admin on Sat Dec 16 05:41:37 GMT 2023

PRIMARY

SUBSTANCE RECORD


					3438DY3589